Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NEUROPSYKOLOGISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.6% 4.7% 4.6% 5.3% 7.7% 7.2% 13.9% 13.6%   Credit score (0-100)   47 45 45 41 30 33 16 17   Credit rating   BBB BBB BBB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,464 1,023 1,387 739 435 233 0.0 0.0   EBITDA   226 288 757 268 46.3 51.3 0.0 0.0   EBIT   204 282 745 268 46.3 51.3 0.0 0.0   Pre-tax profit (PTP)   242.0 319.8 797.9 292.6 68.9 73.5 0.0 0.0   Net earnings   185.8 248.2 619.5 225.8 52.6 56.2 0.0 0.0   Pre-tax profit without non-rec. items   242 320 798 293 68.9 73.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,995 2,243 2,863 1,088 841 797 672 672   Interest-bearing liabilities   703 709 582 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,988 3,378 3,992 1,926 1,598 1,521 672 672   Net Debt   338 368 216 -372 -259 -331 -672 -672     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,464 1,023 1,387 739 435 233 0.0 0.0   Gross profit growth   -30.8% -30.1% 35.6% -46.7% -41.2% -46.5% -100.0% 0.0%   Employees   2 1 1 1 1 1 0 0   Employee growth %   -33.3% -50.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,988 3,378 3,992 1,926 1,598 1,521 672 672   Balance sheet change%   -0.0% 13.1% 18.2% -51.8% -17.1% -4.8% -55.8% 0.0%   Added value   225.8 287.9 757.0 268.0 46.3 51.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -21 -6 -12 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.0% 27.6% 53.7% 36.3% 10.7% 22.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   8.5% 10.5% 22.1% 10.3% 5.3% 6.2% 0.0% 0.0%   ROI %   9.7% 11.9% 25.3% 13.4% 9.6% 11.9% 0.0% 0.0%   ROE %   9.8% 11.7% 24.3% 11.4% 5.5% 6.9% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   66.8% 66.4% 73.2% 56.5% 52.6% 52.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   149.9% 127.9% 28.6% -138.7% -558.8% -644.6% 0.0% 0.0%   Gearing %   35.3% 31.6% 20.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.7% 2.2% 2.3% 4.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   3.0 3.0 3.8 2.3 2.1 2.1 0.0 0.0   Current Ratio   3.0 3.0 3.6 2.3 2.1 2.1 0.0 0.0   Cash and cash equivalent   364.8 340.3 365.5 371.7 258.9 330.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,992.3 2,250.6 2,870.1 1,085.8 838.4 794.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   113 288 757 268 46 51 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   113 288 757 268 46 51 0 0   EBIT / employee   102 282 745 268 46 51 0 0   Net earnings / employee   93 248 619 226 53 56 0 0